1. Home
  2. CHCT vs ENTA Comparison

CHCT vs ENTA Comparison

Compare CHCT & ENTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Community Healthcare Trust Incorporated

CHCT

Community Healthcare Trust Incorporated

HOLD

Current Price

$16.62

Market Cap

493.1M

Sector

Real Estate

ML Signal

HOLD

Logo Enanta Pharmaceuticals Inc.

ENTA

Enanta Pharmaceuticals Inc.

HOLD

Current Price

$13.47

Market Cap

486.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CHCT
ENTA
Founded
2014
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
493.1M
486.3M
IPO Year
2015
2012

Fundamental Metrics

Financial Performance
Metric
CHCT
ENTA
Price
$16.62
$13.47
Analyst Decision
Buy
Strong Buy
Analyst Count
3
5
Target Price
$18.33
$20.40
AVG Volume (30 Days)
339.9K
184.0K
Earning Date
05-20-2026
05-11-2026
Dividend Yield
11.36%
N/A
EPS Growth
134.78
29.93
EPS
0.08
N/A
Revenue
$121,195,000.00
$102,814,000.00
Revenue This Year
$9.06
$5.91
Revenue Next Year
$8.61
N/A
P/E Ratio
$209.63
N/A
Revenue Growth
4.67
16.48
52 Week Low
$13.23
$4.09
52 Week High
$19.01
$17.15

Technical Indicators

Market Signals
Indicator
CHCT
ENTA
Relative Strength Index (RSI) 42.36 44.83
Support Level $16.18 $13.39
Resistance Level $17.34 $13.98
Average True Range (ATR) 0.53 0.86
MACD -0.08 -0.03
Stochastic Oscillator 27.37 15.79

Price Performance

Historical Comparison
CHCT
ENTA

About CHCT Community Healthcare Trust Incorporated

Community Healthcare Trust Inc is an integrated healthcare real estate company in the United States. The company owns and acquires, or finances, real estate properties that are leased to hospitals, doctors, healthcare systems, or other healthcare service providers in non-urban markets. The company derives the majority of its revenues from its real estate property and mortgage notes portfolio. The company's rental and mortgage interest income is recognized based on contractual arrangements with its tenants and borrowers.

About ENTA Enanta Pharmaceuticals Inc.

Enanta Pharmaceuticals Inc is a biotechnology company that uses a chemistry-based drug discovery approach to develop small-molecule candidates for virology and immunology applications. It focuses on Virology and Immunology. Its active development programs in virology are focused on respiratory syncytial virus, or RSV, and SARS-CoV-2, and Hepatitis B virus. In immunology, the company is engaged in designing and developing potent and selective, oral small molecule inhibitors for the treatment of type 2 inflammatory disease. The company has collaborated with AbbVie, which markets its protease inhibitor paritaprevir, with additional inhibitors in development. The company generates the majority revenue in the form of royalty revenue.

Share on Social Networks: